Managing gout needs more than drugs: 'Il faut le savoir-faire, l'Art et la manière'

摘要

Gout management has recently been a topic of active discussion, prompted by several European and international recommendations. Nevertheless, a number of studies have reported a suboptimal level of current gout care, including even poorer adherence to prescribed drugs, than in patients with diabetes or hypertension.5 Quality indicators for the treatment of gout developed to date have focused primarily on the use of allopurinol as the most frequently prescribed urate lowering therapy (ULT), adjustment of the maximal dose according to renal function and serum uric acid (SUA) level measurement.